azomycin has been researched along with Chondrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chezal, JM; Degoul, F; Jouberton, E; Maubert, E; Miot-Noirault, É; Peyrode, C; Voissiere, A | 1 |
| Band, P; Chapman, JD; Fryer, CG; Rabin, HR; Urtasun, RC; Wilson, AF | 1 |
2 other study(ies) available for azomycin and Chondrosarcoma
| Article | Year |
|---|---|
Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Chondrosarcoma; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Nitroimidazoles; Phosphoramide Mustards; Spheroids, Cellular; Tissue Scaffolds | 2017 |
Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.
Topics: Chondrosarcoma; Drug Evaluation; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1977 |